Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Hulio (20mg/0.4mL) |
Active Ingredient: | Adalimumab 50mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Viatris Limited |
Manufacturer: | Terumo Yamaguchi D&D Corporation, Yamaguchi, Japan |
Product: | Hulio (40mg/0.8mL) |
Active Ingredient: | Adalimumab 50mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Viatris Limited |
Manufacturer: | Terumo Yamaguchi D&D Corporation, Yamaguchi, Japan |
Product: | Hulio (40mg/0.8mL Pen) |
Active Ingredient: | Adalimumab 50mg/mL |
Dosage Form: | Solution for injection |
New Zealand Sponsor: | Viatris Limited |
Manufacturer: | Terumo Yamaguchi D&D Corporation, Yamaguchi, Japan |
Product: | Tadalafil Sandoz |
Active Ingredient: | Tadalafil 5mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Intas Pharmaceuticals Limited, Ahmedabad, India |
Product: | Tadalafil Sandoz |
Active Ingredient: | Tadalafil 10mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Intas Pharmaceuticals Limited, Ahmedabad, India |
Product: | Tadalafil Sandoz |
Active Ingredient: | Tadalafil 20mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | Intas Pharmaceuticals Limited, Ahmedabad, India |
Dated this 28th day of September 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).